
CEG · Nasdaq
Reports Nov 6, 2026.
Consensus is $3.96 EPS for Sep 2026 across 3 estimates, ranging $3.52 to $4.40.
Constellation's second quarter was an earnings beat shaped by the first full quarter contribution from Calpine, stronger market and portfolio conditions, and nuclear outage pressure. Adjusted operating EPS was $2.55, 8.05% above the $2.36 consensus and 34% above $1.91 a year ago. GAAP diluted EPS was $1.42, down from $2.67 in the prior-year quarter and $4.49 in the first quarter. Operating revenue was $7.50 billion, up 23% year over year but below the $7.54 billion reported in the prior quarter; operating income fell to $580 million from $951 million a year ago and $2.33 billion in Q1.
The print therefore separates underlying earnings from GAAP volatility and integration accounting. Calpine contributed $1.91 billion of revenue after its January acquisition, but the quarter also included $149 million of after-tax amortization of acquired commodity contracts and $84 million of after-tax merger and integration costs in the reconciliation. Nuclear output and capacity factor declined as refueling outages more than doubled, although favorable markets and the expanded fleet supported adjusted earnings. Management raised full-year adjusted EPS guidance to $11.50-$12.50 and used the quarter to advance the longer-term platform through 920 MW of new nuclear PPAs, Crane restart approvals, New York license-renewal filings, and the final required Calpine-related divestiture.
Adjusted operating earnings increased despite lower GAAP profitability, reflecting the Calpine addition and favorable market and portfolio conditions. GAAP results were affected by fair-value movements, decommissioning items, acquired contract amortization, and merger-related costs.
Calpine is now a separate reportable segment and materially changed the scale and mix of Constellation's results. The acquisition added dispatchable generation, retail load, and market diversification, but also increased depreciation, financing costs, integration expenses, and balance-sheet complexity.
Nuclear availability was a clear operating headwind. Generation declined modestly year over year, but the larger increase in planned refueling outages reduced the operated fleet's capacity factor. Constellation is simultaneously extending the commercial and regulatory life of its nuclear platform.
The quarter added contracted visibility for clean, reliable generation as Constellation positioned nuclear assets to serve rising electricity demand. The new PPAs are long-dated and begin well beyond the current reporting period.
Constellation continued to reshape the acquired Calpine portfolio while funding elevated investment and integration needs. The Brazos transaction is the final asset sale required by the DOJ resolution, but closing remains subject to approval and customary conditions.